Sterling Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$11.3K Buy
2025
Q2
$4.68K Buy
2025
Q1
$3.85K Sell
2024
Q4
$13.7K Buy
2024
Q3
$1.44K Buy